Unum Group

UNMNYSEUSD

THESIS ALERT

Email me when the UNM thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$81.37
+$0.13 (+0.16%)Today 1M −11.24%
After hours$81.370.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$81.24
Prior regular-session close from the quote source.
$80.03–$81.51
Regular-session low and high so far today.
1.4M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 4 projected
Projected for 2027-02-04 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$69.02–$96.77
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own UNM if Unum is a low-cost operator of essential employer‑sponsored disability, life and voluntary benefits whose earnings power depends on stable benefit experience and investment returns, with capital management and reinsurance used to smooth volatility and.

UNM price history

Latest price$81.37Today+$0.13 (+0.16%)
UNM -12.60%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • Employer-sponsored group benefits are sufficiently essential and distributionally sticky that consolidated revenue will remain stable-to-growing absent a deep labor-market shock; revenue is the observable confirmation of that resilience.StrengtheningMateriality: High

    Revenue grew from $11.984B in 2022 to $13.0755B in 2025 (annual revenues: 2022, 2023, 2024, 2025). If demand for employer-sponsored benefits holds, Unum converts fixed underwriting and distribution costs into stable profits and cash; if employers materially cut benefits adoption, top-line and underwriting scale evaporate.

    Watch: A macro recession that forces employers to cut benefits or freeze voluntary offerings and aggregate group enrollment declines.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenue grew from $11.984B in 2022 to $13.0755B in 2025 (annual revenues: 2022, 2023, 2024, 2025).

    Open source ↗
  • Unum's GAAP profitability is highly sensitive to reserve assumption updates and investment marks — those drivers, not core sales, explain large year-to-year swings in net income.StrengtheningMateriality: High

    Net income fell from $1.7791B in 2024 to $738.5M in 2025. If reserve and investment volatility abates, GAAP earnings should revert closer to adjusted operating income; if adverse reserve or investment shocks recur, GAAP earnings and capital returns will be impaired.

    Watch: A persistent rise in morbidity/claims (worse benefit ratios) across Unum US and Colonial Life that keeps benefit ratios structurally higher.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Net income fell from $1.7791B in 2024 to $738.5M in 2025.

    Open source ↗
  • Operating cash flow will recover toward historical mid‑$1B levels if underwriting benefit ratios normalize and investment cash interest yields improve; operating_cash_flow is the leading cash confirmation.HoldingMateriality: Medium

    Operating cash flow declined from $1.5132B in 2024 to $687.7M in 2025, tracking the GAAP earnings decline. Free cash generation funds dividends, buybacks, and de‑leveraging; weak or volatile cash flow forces capital conservation and caps returns to shareholders.

    Watch: Sustained elevated benefit ratios (worse claims experience) or higher reserve strengthening that increases cash funding needs.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow declined from $1.5132B in 2024 to $687.7M in 2025, tracking the GAAP earnings decline.

    Open source ↗
  • Management has preserved equity and balance-sheet capacity (via reinsurance and other transactions) to maintain solvency and return capital; stockholder equity trends will show continued capacity to pay dividends and repurchase when earnings normalize.StrengtheningMateriality: Medium

    Stockholders' equity increased from $8.735B in 2022 to $11.1191B in 2025 (instant balances), indicating balance-sheet rebuild despite 2025 headwinds. If equity and capital ratios remain strong, Unum can sustain buybacks/dividends supporting per‑share value; if capital erodes from reserve/investment hits, capital returns will be cut.

    Watch: Large, repeated reserve assumption increases or adverse regulatory capital requirements that materially draw down equity.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Stockholders' equity increased from $8.735B in 2022 to $11.1191B in 2025 (instant balances), indicating balance-sheet rebuild despite 2025 headwinds.

    Open source ↗
  • For the current multiple to be justified, diluted EPS must recover materially above the 2025 GAAP trough and reflect sustained adjusted operating income — eps_diluted is the shareholder-level signal of that recovery.HoldingMateriality: Medium

    GAAP diluted EPS fell from $9.46 in 2024 to $4.27 in 2025, while MD&A reports adjusted operating income per diluted share of $8.13 in 2025 (non‑GAAP), showing scope for reconciliation if one‑offs normalize. If EPS does not recover, the multiple will compress; if EPS recovers above adjusted levels, the stock can re-rate and produce total return, especially given a modest P/B.

    Watch: Persistent reserve strengthening or recurring investment losses that keep GAAP EPS depressed.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP diluted EPS fell from $9.46 in 2024 to $4.27 in 2025, while MD&A reports adjusted operating income per diluted.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Employer-sponsored group benefits are sufficiently essential and distributionally sticky that consolidated revenue will remain stable-to-growing absent a deep labor-market shock; revenue is the observable confirmation of that resilience. If demand for employer-sponsored benefits holds, Unum converts fixed underwriting and distribution costs into stable profits and cash; if employers materially cut benefits adoption, top-line and underwriting scale evaporate.

Unum's GAAP profitability is highly sensitive to reserve assumption updates and investment marks — those drivers, not core sales, explain large year-to-year swings in net income. If reserve and investment volatility abates, GAAP earnings should revert closer to adjusted operating income; if adverse reserve or investment shocks recur, GAAP earnings and capital returns will be impaired.

Operating cash flow will recover toward historical mid‑$1B levels if underwriting benefit ratios normalize and investment cash interest yields improve; operating_cash_flow is the leading cash confirmation. Free cash generation funds dividends, buybacks, and de‑leveraging; weak or volatile cash flow forces capital conservation and caps returns to shareholders.

Management has preserved equity and balance-sheet capacity (via reinsurance and other transactions) to maintain solvency and return capital; stockholder equity trends will show continued capacity to pay dividends and repurchase when earnings normalize. If equity and capital ratios remain strong, Unum can sustain buybacks/dividends supporting per‑share value; if capital erodes from reserve/investment hits, capital returns will be cut.

For the current multiple to be justified, diluted EPS must recover materially above the 2025 GAAP trough and reflect sustained adjusted operating income — eps_diluted is the shareholder-level signal of that recovery. If EPS does not recover, the multiple will compress; if EPS recovers above adjusted levels, the stock can re-rate and produce total return, especially given a modest P/B.

All standing thesis claims
Original report summary

Unum is a low-cost operator of essential employer‑sponsored disability, life and voluntary benefits whose earnings power depends on stable benefit experience and investment returns, with capital management and reinsurance used to smooth volatility and.

Evidence assessed Nov 7, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Unum Group

Where the evidence on Unum Group stands: Holding on the latest evidence (Nov 7, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.

Bull case: what the evidence supports

  • Employer-sponsored group benefits are sufficiently essential and distributionally sticky that consolidated revenue will remain stable-to-growing absent a deep labor-market shock; revenue is the observable confirmation of that resilience.

    sec.gov ↗

  • Unum's GAAP profitability is highly sensitive to reserve assumption updates and investment marks — those drivers, not core sales, explain large year-to-year swings in net income.

    sec.gov ↗

  • Operating cash flow will recover toward historical mid‑$1B levels if underwriting benefit ratios normalize and investment cash interest yields improve; operating_cash_flow is the leading cash confirmation.

    sec.gov ↗

  • Management has preserved equity and balance-sheet capacity (via reinsurance and other transactions) to maintain solvency and return capital; stockholder equity trends will show continued capacity to pay dividends and repurchase when earnings normalize.

    sec.gov ↗

  • For the current multiple to be justified, diluted EPS must recover materially above the 2025 GAAP trough and reflect sustained adjusted operating income — eps_diluted is the shareholder-level signal of that recovery.

    sec.gov ↗

Bear case: what would count against it

  • A macro recession that forces employers to cut benefits or freeze voluntary offerings and aggregate group enrollment declines.

    sec.gov ↗

  • A persistent rise in morbidity/claims (worse benefit ratios) across Unum US and Colonial Life that keeps benefit ratios structurally higher.

    sec.gov ↗

  • Sustained elevated benefit ratios (worse claims experience) or higher reserve strengthening that increases cash funding needs.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Unum Group

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed Unum Group’s thesis. Its break conditions are checked against every new filing as it lands.

Early warning

The break condition read on the trailing twelve months through Unum Group’s latest quarterly report, ahead of the annual figure it is written on.

  • Net loss, trailing 12 months

    Across all companies, this kind of early warning has happened 2,059 times before. Those stocks beat the market by a median of 1% over the next six months, and 35% of them trailed it by 10 points or more.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Unum Group filed an SEC 8-K on 2026-11-03: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Other material event.

    Unum Group filed an SEC 8-K on 2026-08-26: Other material event. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Unum Group filed an SEC 8-K on 2026-07-28: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • A macro recession that forces employers to cut benefits or freeze voluntary offerings and aggregate group enrollment declines.
  • A persistent rise in morbidity/claims (worse benefit ratios) across Unum US and Colonial Life that keeps benefit ratios structurally higher.
  • Sustained elevated benefit ratios (worse claims experience) or higher reserve strengthening that increases cash funding needs.
  • Large, repeated reserve assumption increases or adverse regulatory capital requirements that materially draw down equity.
  • Persistent reserve strengthening or recurring investment losses that keep GAAP EPS depressed.

UNM news

Loading headlines…

Financial statements

UNM income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

UNM: quick answers

When does Unum Group (UNM) report earnings next?
Unum Group's next results are projected for February 4, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 3, 2026. Earnings calendar
What is UNM's short interest?
As of October 30, 2026, 5.0M UNM shares were sold short, 3.20% of its shares outstanding, up 0.5% from the count before. At the stock's average daily volume that is 3.7 days to cover. FINRA publishes the count twice a month. UNM short interest history
Have members of Congress traded UNM?
11 trades in UNM have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed UNM trade
Which well-known investors own UNM?
1 of the 37 well-known funds tracked here reported UNM shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.1%. Fund portfolios

UNM in well-known investors’ portfolios

1 of 37 funds reported UNM shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Ray DalioBridgewater Associates0.08%$20.3M−8.4%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.